Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Open-label, Single Arm, Single Center Clinical Study In Healthy Subjects to Qualify an In-house Reference Standard Batch of Sci-B-Vac

Trial Profile

An Open-label, Single Arm, Single Center Clinical Study In Healthy Subjects to Qualify an In-house Reference Standard Batch of Sci-B-Vac

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jun 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Hepatitis B vaccine recombinant (Primary)
  • Indications Hepatitis B
  • Focus Pharmacodynamics
  • Sponsors VBI Vaccines

Most Recent Events

  • 28 Jun 2022 Last checked against ClinicalTrials.gov record.
  • 26 Jun 2021 Results assessing speed to seroprotection, immunogenicity and safety of prophylactic HBV vaccine from five clinical trials: PROTECT, CONSTANT, SG-005-05, 38-13-040 and SciB018 presented at The International Liver Congress 2021
  • 15 Jan 2021 Primary endpoint (Seroprotection rate achieved one month after the third immunization with Sci-B-Vac) has been met, according to a VBI Vaccines media release.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top